Suppr超能文献

日本研发的无线贴片式心电图监测系统杜兰塔(Duranta)在检测隐源性卒中患者隐匿性房颤中的应用:一例报告。

Utility of Duranta, a wireless patch-type electrocardiographic monitoring system developed in Japan, in detecting covert atrial fibrillation in patients with cryptogenic stroke: A case report.

作者信息

Akiyama Hisanao, Nukui Saki, Araga Takashi, Hoshino Masashi, Tanaka Keita, Kashima Satoru, Sasaki Rie, Uchino Kenji, Hasegawa Yasuhiro

机构信息

Department of Neurology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.

出版信息

Medicine (Baltimore). 2017 Feb;96(6):e5995. doi: 10.1097/MD.0000000000005995.

Abstract

RATIONALE

Subcutaneous implantable electrocardiographs are highly effective in detecting covert atrial fibrillation (AF) in cryptogenic stroke. However, these invasive devices are not indicated for all cryptogenic stroke patients, and noninvasive improvements over conventional Holter-type ambulatory electrocardiography are needed. We evaluated the clinical application and effectiveness of Duranta (ImageONE Co., Ltd.), a wireless patch-type electrocardiographic monitoring system developed in Japan for chronically ill patients or home-based patients at the end of life. A Duranta device was used to detect covert AF in patients with acute ischemic stroke of undetermined source with no sign of AF during cardiographic monitoring ≥24 hours postadmission.

PATIENT CONCERNS

A 72-year-old man with severe aortic stenosis was admitted to our hospital with dysarthria and right upper limb weakness. Diffusion-weighted plain head magnetic resonance imaging (MRI) showed acute cerebral infarctions across the left middle cerebral artery territory. Twelve-lead electrocardiography, Holter-type ambulatory electrocardiography, and cardiographic monitoring for ≥24 hours revealed no AF, indicating a probable diagnosis of artery-to-artery embolism following left common carotid artery stenosis detected by carotid ultrasound imaging and cerebral angiography.

INTERVENTIONS

However, because of high blood brain natriuretic peptide (BNP) and valvular heart disease, continuous monitoring using Duranta was performed from the 2nd to 13th days after onset to exclude possible cardioembolic stroke. Waveform and heart rate trend graph analysis showed paroxysmal AF (PAF) occurred on the 5th and 9th days after onset. PAF did not occur at any other time during the observation period. The quality of the cardiograms sufficed for analysis and diagnosis of AF. The lightweight compact device can be placed quickly with no movement restriction. These features and our findings show the usefulness of the Duranta device for long-term continuous monitoring.

LESSONS

A noninvasive wireless patch-type electrocardiographic monitoring system, Duranta, placed at the precordium, was useful in detecting covert AF in cryptogenic stroke patients, warranting further investigation.

摘要

原理

皮下植入式心电图仪在检测隐源性卒中患者的隐匿性心房颤动(AF)方面非常有效。然而,这些侵入性设备并非适用于所有隐源性卒中患者,因此需要对传统动态心电图(Holter)进行非侵入性改进。我们评估了Duranta(ImageONE有限公司)的临床应用和有效性,这是一种日本研发的无线贴片式心电图监测系统,适用于慢性病患者或临终居家患者。在入院后≥24小时的心电图监测期间,Duranta设备用于检测急性缺血性卒中病因不明且无房颤迹象的患者的隐匿性房颤。

患者情况

一名72岁严重主动脉瓣狭窄男性因构音障碍和右上肢无力入院。头颅扩散加权磁共振成像(MRI)显示左侧大脑中动脉区域急性脑梗死。十二导联心电图、动态心电图监测以及≥24小时的心电图监测均未发现房颤,经颈动脉超声成像和脑血管造影检查发现左侧颈总动脉狭窄,提示可能为动脉到动脉栓塞。

干预措施

然而,由于患者脑钠肽(BNP)水平较高且存在瓣膜性心脏病,因此在发病后第2天至第13天使用Duranta进行持续监测,以排除可能的心源性栓塞性卒中。波形和心率趋势图分析显示,发病后第5天和第9天出现阵发性房颤(PAF)。观察期内其他时间未出现PAF。心电图质量足以用于房颤的分析和诊断。该设备轻巧紧凑,放置迅速,且不限制活动。这些特点及我们的研究结果表明Duranta设备用于长期连续监测很有用。

经验教训

置于胸前区的非侵入性无线贴片式心电图监测系统Duranta,在检测隐源性卒中患者的隐匿性房颤方面很有用,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0164/5312997/8d40ae4131ce/medi-96-e5995-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验